A case of ureteral fungal mass removal in a patient taking empagliflozin
With increased use of sodium-glucose co-transporter 2 (SGLT2) inhibitors as antidiabetic
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
A case of ureteral fungal mass removal in a patient taking empagliflozin
A Woloshuk, M Lee, M Assmus, D Agarwal… - 2021 - scholarworks.iupui.edu
With increased use of sodium-glucose co-transporter 2 (SGLT2) inhibitors as antidiabetic
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
A case of ureteral fungal mass removal in a patient taking empagliflozin
A Woloshuk, M Lee, M Assmus… - CEN case …, 2021 - scholars.northwestern.edu
With increased use of sodium-glucose co-transporter 2 (SGLT2) inhibitors as antidiabetic
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
A case of ureteral fungal mass removal in a patient taking empagliflozin
A Woloshuk, M Lee, M Assmus, D Agarwal… - CEN case …, 2021 - experts.umn.edu
With increased use of sodium-glucose co-transporter 2 (SGLT2) inhibitors as antidiabetic
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
A case of ureteral fungal mass removal in a patient taking empagliflozin.
A Woloshuk, M Lee, M Assmus, D Agarwal… - CEN Case …, 2021 - europepmc.org
With increased use of sodium-glucose co-transporter 2 (SGLT2) inhibitors as antidiabetic
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
A case of ureteral fungal mass removal in a patient taking empagliflozin
A Woloshuk, M Lee, M Assmus… - CEN case …, 2021 - ohiostate.elsevierpure.com
With increased use of sodium-glucose co-transporter 2 (SGLT2) inhibitors as antidiabetic
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
A case of ureteral fungal mass removal in a patient taking empagliflozin
A Woloshuk, M Lee, M Assmus… - CEN case …, 2021 - pubmed.ncbi.nlm.nih.gov
With increased use of sodium-glucose co-transporter 2 (SGLT2) inhibitors as antidiabetic
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
[HTML][HTML] A case of ureteral fungal mass removal in a patient taking empagliflozin
A Woloshuk, M Lee, M Assmus, D Agarwal… - CEN Case …, 2021 - ncbi.nlm.nih.gov
With increased use of sodium-glucose co-transporter 2 (SGLT2) inhibitors as antidiabetic
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …
agents, the risk of serious fungal urinary tract infection (UTI) may be increased. We present …